Cargando…

Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells

BACKGROUND: The worldwide increasing number of people with chronic diseases is pushing conventional therapy to its limits. The so-called Major AutoHaemo Therapy (MAH) has been used in many practices for years. Despite suspicions, especially the 10-passes ozone-high-dosis Therapy (OHT) has shown subs...

Descripción completa

Detalles Bibliográficos
Autores principales: König, Brigitte, Lahodny, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301618/
https://www.ncbi.nlm.nih.gov/pubmed/35880042
http://dx.doi.org/10.1186/s41231-022-00123-7
_version_ 1784751457158823936
author König, Brigitte
Lahodny, Johann
author_facet König, Brigitte
Lahodny, Johann
author_sort König, Brigitte
collection PubMed
description BACKGROUND: The worldwide increasing number of people with chronic diseases is pushing conventional therapy to its limits. The so-called Major AutoHaemo Therapy (MAH) has been used in many practices for years. Despite suspicions, especially the 10-passes ozone-high-dosis Therapy (OHT) has shown substantial benefits in chronic ailments. However, knowledge of scientifically based effects of high ozone concentrations are still rare. The present investigation focussed on verifying whether OHT may be linked to a beneficial effect on mitochondrial bioenergetics which can be expressed as a bioenergetic health index (BHI). METHODS: We report on six patients which received OHT for preventive purposes twice within one week. The BHI in peripheral blood mononuclear cells (PBMC) is calculated from parameters of a cellular mitochondrial function assay, which gives insights into different aspects of mitochondrial function: 1) Basal oxygen consumption rate (OCR); 2) ATP-linked OCR and proton leak; 3) Maximal OCR and reserve capacity; 4) Non-mitochondrial OCR. RESULTS: The results clearly show that the bioenergetic health index in PBMC improves significantly after just 2 OHT applications over a period of 1 week. The overall improvement of the BHI is based primarily on a significant increase in the reserve capacity and the maximum respiration of the mitochondria. The increase in non-mitochondrial oxygen consumption, which has a negative impact on the BHI value, is indicative for the Nrf-2 dependent activation of antioxidant and detoxifying enzymes activated through OHT. CONCLUSION: These data demonstrate for the first time the beneficial effect of OHT on mitochondrial parameters. Thus, the results of this study suggest that OHT could be a safe and effective therapeutic option alone or as integrative and complementary support for pharmacological therapy in a variety of chronic and acute diseases where mitochondrial dysfunction plays a central role.
format Online
Article
Text
id pubmed-9301618
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93016182022-07-21 Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells König, Brigitte Lahodny, Johann Transl Med Commun Research BACKGROUND: The worldwide increasing number of people with chronic diseases is pushing conventional therapy to its limits. The so-called Major AutoHaemo Therapy (MAH) has been used in many practices for years. Despite suspicions, especially the 10-passes ozone-high-dosis Therapy (OHT) has shown substantial benefits in chronic ailments. However, knowledge of scientifically based effects of high ozone concentrations are still rare. The present investigation focussed on verifying whether OHT may be linked to a beneficial effect on mitochondrial bioenergetics which can be expressed as a bioenergetic health index (BHI). METHODS: We report on six patients which received OHT for preventive purposes twice within one week. The BHI in peripheral blood mononuclear cells (PBMC) is calculated from parameters of a cellular mitochondrial function assay, which gives insights into different aspects of mitochondrial function: 1) Basal oxygen consumption rate (OCR); 2) ATP-linked OCR and proton leak; 3) Maximal OCR and reserve capacity; 4) Non-mitochondrial OCR. RESULTS: The results clearly show that the bioenergetic health index in PBMC improves significantly after just 2 OHT applications over a period of 1 week. The overall improvement of the BHI is based primarily on a significant increase in the reserve capacity and the maximum respiration of the mitochondria. The increase in non-mitochondrial oxygen consumption, which has a negative impact on the BHI value, is indicative for the Nrf-2 dependent activation of antioxidant and detoxifying enzymes activated through OHT. CONCLUSION: These data demonstrate for the first time the beneficial effect of OHT on mitochondrial parameters. Thus, the results of this study suggest that OHT could be a safe and effective therapeutic option alone or as integrative and complementary support for pharmacological therapy in a variety of chronic and acute diseases where mitochondrial dysfunction plays a central role. BioMed Central 2022-07-21 2022 /pmc/articles/PMC9301618/ /pubmed/35880042 http://dx.doi.org/10.1186/s41231-022-00123-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
König, Brigitte
Lahodny, Johann
Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells
title Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells
title_full Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells
title_fullStr Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells
title_full_unstemmed Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells
title_short Ozone high dose therapy (OHT) improves mitochondrial bioenergetics in peripheral blood mononuclear cells
title_sort ozone high dose therapy (oht) improves mitochondrial bioenergetics in peripheral blood mononuclear cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301618/
https://www.ncbi.nlm.nih.gov/pubmed/35880042
http://dx.doi.org/10.1186/s41231-022-00123-7
work_keys_str_mv AT konigbrigitte ozonehighdosetherapyohtimprovesmitochondrialbioenergeticsinperipheralbloodmononuclearcells
AT lahodnyjohann ozonehighdosetherapyohtimprovesmitochondrialbioenergeticsinperipheralbloodmononuclearcells